Pharma & Healthcare

Global Covid-19 Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

The global Covid-19 Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
By Type: (Dominant Segment vs High-Margin Innovation)
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Adults
Children
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Moderna in Europe)
- Emerging Product Trends: DNA adoption vs. Non-replicating Viral Vector premiumization
- Demand-Side Dynamics: Adults growth in China vs. Children potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Covid-19 Vaccine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-replicating Viral Vector in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Children in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Covid-19 Vaccine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Vaccine Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Covid-19 Vaccine Revenue Market Share by Region (2020-2025)
2.4 Global Covid-19 Vaccine Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.2 Europe Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.3 China Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.4 Japan Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.6 India Covid-19 Vaccine Market Size and Prospective (2020-2031)
2.5.7 Central & South America Covid-19 Vaccine Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Covid-19 Vaccine Historic Market Size by Type (2020-2025)
3.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2026-2031)
3.3 Different Types Covid-19 Vaccine Representative Players
4 Breakdown Data by Application
4.1 Global Covid-19 Vaccine Historic Market Size by Application (2020-2025)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Covid-19 Vaccine Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Covid-19 Vaccine Players by Revenue (2020-2025)
5.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
5.4 Global Covid-19 Vaccine Market Concentration Analysis
5.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2024
5.5 Global Key Players of Covid-19 Vaccine Head office and Area Served
5.6 Global Key Players of Covid-19 Vaccine, Product and Application
5.7 Global Key Players of Covid-19 Vaccine, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Covid-19 Vaccine Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Covid-19 Vaccine Market Size by Type (2020-2025)
6.1.2.2 North America Covid-19 Vaccine Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Covid-19 Vaccine Market Size by Application (2020-2025)
6.1.3.2 North America Covid-19 Vaccine Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Covid-19 Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Covid-19 Vaccine Market Size by Type (2020-2025)
6.2.2.2 Europe Covid-19 Vaccine Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Covid-19 Vaccine Market Size by Application (2020-2025)
6.2.3.2 Europe Covid-19 Vaccine Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Covid-19 Vaccine Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Covid-19 Vaccine Market Size by Type (2020-2025)
6.3.2.2 China Covid-19 Vaccine Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Covid-19 Vaccine Market Size by Application (2020-2025)
6.3.3.2 China Covid-19 Vaccine Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Covid-19 Vaccine Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Covid-19 Vaccine Market Size by Type (2020-2025)
6.4.2.2 Japan Covid-19 Vaccine Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Covid-19 Vaccine Market Size by Application (2020-2025)
6.4.3.2 Japan Covid-19 Vaccine Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Covid-19 Vaccine Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Covid-19 Vaccine Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Covid-19 Vaccine Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Covid-19 Vaccine Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Covid-19 Vaccine Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Covid-19 Vaccine Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Covid-19 Vaccine Market Size by Type (2020-2025)
6.6.2.2 India Covid-19 Vaccine Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Covid-19 Vaccine Market Size by Application (2020-2025)
6.6.3.2 India Covid-19 Vaccine Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Moderna
7.1.1 Moderna Company Details
7.1.2 Moderna Business Overview
7.1.3 Moderna Covid-19 Vaccine Introduction
7.1.4 Moderna Revenue in Covid-19 Vaccine Business (2020-2025)
7.1.5 Moderna Recent Development
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Company Details
7.2.2 CanSino Biologicals Business Overview
7.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
7.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2020-2025)
7.2.5 CanSino Biologicals Recent Development
7.3 Inovio Pharmaceuticals
7.3.1 Inovio Pharmaceuticals Company Details
7.3.2 Inovio Pharmaceuticals Business Overview
7.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
7.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2020-2025)
7.3.5 Inovio Pharmaceuticals Recent Development
7.4 Shenzhen Geno-Immune Medical Institute
7.4.1 Shenzhen Geno-Immune Medical Institute Company Details
7.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
7.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
7.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2020-2025)
7.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
7.5 GlaxoSmithKine
7.5.1 GlaxoSmithKine Company Details
7.5.2 GlaxoSmithKine Business Overview
7.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
7.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2020-2025)
7.5.5 GlaxoSmithKine Recent Development
7.6 Pfizer
7.6.1 Pfizer Company Details
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Covid-19 Vaccine Introduction
7.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2020-2025)
7.6.5 Pfizer Recent Development
7.7 Johnson＆Johnson
7.7.1 Johnson＆Johnson Company Details
7.7.2 Johnson＆Johnson Business Overview
7.7.3 Johnson＆Johnson Covid-19 Vaccine Introduction
7.7.4 Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2020-2025)
7.7.5 Johnson＆Johnson Recent Development
7.8 Heat Biologics
7.8.1 Heat Biologics Company Details
7.8.2 Heat Biologics Business Overview
7.8.3 Heat Biologics Covid-19 Vaccine Introduction
7.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2020-2025)
7.8.5 Heat Biologics Recent Development
7.9 Sanofi
7.9.1 Sanofi Company Details
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Covid-19 Vaccine Introduction
7.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2020-2025)
7.9.5 Sanofi Recent Development
8 Covid-19 Vaccine Market Dynamics
8.1 Covid-19 Vaccine Industry Trends
8.2 Covid-19 Vaccine Market Drivers
8.3 Covid-19 Vaccine Market Challenges
8.4 Covid-19 Vaccine Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Covid-19 Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Covid-19 Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Covid-19 Vaccine Revenue Share by Region (2020-2025)
Table 6. Global Covid-19 Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Covid-19 Vaccine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Covid-19 Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Covid-19 Vaccine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Covid-19 Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Covid-19 Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Covid-19 Vaccine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Covid-19 Vaccine Application
Table 18. Global Covid-19 Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Covid-19 Vaccine Market Share by Players (2020-2025)
Table 20. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2024)
Table 21. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Covid-19 Vaccine, Headquarters and Area Served
Table 24. Global Key Players of Covid-19 Vaccine, Product and Application
Table 25. Global Key Players of Covid-19 Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 29. North America Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 33. Europe Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 37. China Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 41. Japan Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Covid-19 Vaccine Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Covid-19 Vaccine Revenue Market Share by Company (2020-2025)
Table 49. India Covid-19 Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Covid-19 Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 51. Moderna Company Details
Table 52. Moderna Business Overview
Table 53. Moderna Covid-19 Vaccine Product
Table 54. Moderna Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 55. Moderna Recent Development
Table 56. CanSino Biologicals Company Details
Table 57. CanSino Biologicals Business Overview
Table 58. CanSino Biologicals Covid-19 Vaccine Product
Table 59. CanSino Biologicals Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 60. CanSino Biologicals Recent Development
Table 61. Inovio Pharmaceuticals Company Details
Table 62. Inovio Pharmaceuticals Business Overview
Table 63. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 64. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 65. Inovio Pharmaceuticals Recent Development
Table 66. Shenzhen Geno-Immune Medical Institute Company Details
Table 67. Shenzhen Geno-Immune Medical Institute Business Overview
Table 68. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 69. Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 70. Shenzhen Geno-Immune Medical Institute Recent Development
Table 71. GlaxoSmithKine Company Details
Table 72. GlaxoSmithKine Business Overview
Table 73. GlaxoSmithKine Covid-19 Vaccine Product
Table 74. GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 75. GlaxoSmithKine Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Covid-19 Vaccine Product
Table 79. Pfizer Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Johnson＆Johnson Company Details
Table 82. Johnson＆Johnson Business Overview
Table 83. Johnson＆Johnson Covid-19 Vaccine Product
Table 84. Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 85. Johnson＆Johnson Recent Development
Table 86. Heat Biologics Company Details
Table 87. Heat Biologics Business Overview
Table 88. Heat Biologics Covid-19 Vaccine Product
Table 89. Heat Biologics Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 90. Heat Biologics Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Covid-19 Vaccine Product
Table 94. Sanofi Revenue in Covid-19 Vaccine Business (2020-2025) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Covid-19 Vaccine Market Trends
Table 97. Covid-19 Vaccine Market Drivers
Table 98. Covid-19 Vaccine Market Challenges
Table 99. Covid-19 Vaccine Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources


List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Market Share by Type: 2024 VS 2031
Figure 3. DNA Features
Figure 4. Non-replicating Viral Vector Features
Figure 5. Protein Subunit Features
Figure 6. RNA Features
Figure 7. Others Features
Figure 8. Global Covid-19 Vaccine Market Share by Application: 2024 VS 2031
Figure 9. Adults
Figure 10. Children
Figure 11. Covid-19 Vaccine Report Years Considered
Figure 12. Global Covid-19 Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Covid-19 Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Covid-19 Vaccine Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Southeast Asia Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Central & South America Covid-19 Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Covid-19 Vaccine Market Share by Players in 2024
Figure 23. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2024
Figure 25. North America Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 26. North America Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 27. Europe Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 28. Europe Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 29. China Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 30. China Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 31. Japan Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 32. Japan Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 33. Southeast Asia Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 34. Southeast Asia Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 35. India Covid-19 Vaccine Market Share by Type (2020-2025)
Figure 36. India Covid-19 Vaccine Market Share by Application (2020-2025)
Figure 37. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 38. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 39. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 40. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 41. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 42. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 43. Johnson＆Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 44. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 45. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies